---
title: 'Tricking the Trickster: Precision Medicine Approaches to Counteract Leukemia
  Immune Escape after Transplant'
date: '2024-05-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38728431/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240511181524&v=2.18.0.post9+e462414
source: Blood
description: Over the last decades, significant improvements in reducing the toxicities
  of allogeneic hematopoietic cell transplantation (allo-HCT) have widened its use
  as consolidation or salvage therapy for high-risk hematological malignancies. Nevertheless,
  relapse of the original malignant disease remains an open issue, with unsatisfactory
  salvage options and limited rationales to select amongst them. In the last years,
  a number of studies have highlighted that relapse is often associated to ...
disable_comments: true
---
Over the last decades, significant improvements in reducing the toxicities of allogeneic hematopoietic cell transplantation (allo-HCT) have widened its use as consolidation or salvage therapy for high-risk hematological malignancies. Nevertheless, relapse of the original malignant disease remains an open issue, with unsatisfactory salvage options and limited rationales to select amongst them. In the last years, a number of studies have highlighted that relapse is often associated to ...